Amplo Biotechnology Overview
- Year Founded
-
2019
- Status
-
Private
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$3M
- Investors
-
5
Amplo Biotechnology General Information
Description
Developer of adeno-associated viral (AAV) therapies designed to focus on cures for defects related to the neuromuscular junction. The company's therapies target defects in neuromuscular junction formation, such as paralysis, breathing, and swallowing difficulties, and are given via intravascular injection that triggers the activation of molecular events, enabling doctors to treat patients suffering from congenital myasthenic syndromes.
Contact Information
Website
www.amplobiotechnology.comCorporate Office
- 2637 East Atlantic Boulevard
- Suite 43644
- Pompano Beach, FL 33062-4939
- United States
Corporate Office
- 2637 East Atlantic Boulevard
- Suite 43644
- Pompano Beach, FL 33062-4939
- United States
Amplo Biotechnology Timeline
Amplo Biotechnology Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Grant | 01-Sep-2024 | $3M | Completed | Clinical Trials - General | ||
| 4. Grant | 01-Jun-2023 | Completed | Clinical Trials - General | |||
| 3. Grant | 01-Jun-2022 | Completed | Clinical Trials - General | |||
| 2. Grant | 28-Feb-2022 | $254K | $2.24M | Completed | Clinical Trials - General | |
| 1. Seed Round | 01-Oct-2021 | $2.24M | $2.24M | Completed | Clinical Trials - General |
Amplo Biotechnology Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed |
Amplo Biotechnology Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| NIH Seed | Not-For-Profit Venture Capital | |||
| U.S. Department of Health and Human Services | Government | |||
| Biobrit | Venture Capital | Minority | ||
| Casdin Capital | Venture Capital | Minority | ||
| SeedFolio | Venture Capital | Minority |
Amplo Biotechnology FAQs
-
When was Amplo Biotechnology founded?
Amplo Biotechnology was founded in 2019.
-
Where is Amplo Biotechnology headquartered?
Amplo Biotechnology is headquartered in Pompano Beach, FL.
-
What industry is Amplo Biotechnology in?
Amplo Biotechnology’s primary industry is Drug Discovery.
-
Is Amplo Biotechnology a private or public company?
Amplo Biotechnology is a Private company.
-
What is Amplo Biotechnology’s current revenue?
The current revenue for Amplo Biotechnology is .
-
How much funding has Amplo Biotechnology raised over time?
Amplo Biotechnology has raised $2.24M.
-
Who are Amplo Biotechnology’s investors?
NIH Seed, U.S. Department of Health and Human Services, Biobrit, Casdin Capital, and SeedFolio have invested in Amplo Biotechnology.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process